COMPANY PROFILE

Owkin

Explore full profile

Collaborative research platform and unique AI drug development solutions that make precision medicine a reality

Paris, FranceFounded 2016Biotech & Life Sciences

Valuation $1–2.5B Last recorded · Mar/2026

Revenue $10–50M Latest reported FY

Headcount 100–500 Current team size

Unlock exact values

At a glance

Founded: 2016
Headquarters: Paris, France
Sector: Biotech & Life Sciences
Power Law: Unicorn$1–10B valuation tierColt$25–100M revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

News Norbert Health raises $14M to give nursing robots clinical skills Sep 1, 2026

Market map Security for AI

Investors

28 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed4 investors entered at this stage

NCNJF Capital
SFShana Fisher
JCJean-Paul Clozel
NJNicole Junkermann

Series A10 investors entered at this stage

Series B and later14 investors entered at this stage

BSBristol-Myers Squibb
CICNRS Innovation
SISISTAFUND
ININRIA
OVOTB Ventures
SASanofi
GAGoogle for Startups Accelerator
ACAlpha Intelligence Capital
ÉUÉcole normale supérieure – PSL University
SESerena
FCFrench National Centre for Scientific Research - CNRS
EHEIT Health
KAKarista
PUPSL University

Ownership

Share of equity by holder

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (Mar/2026). Percentages are indicative.

27.5% Founders

Some investors are hidden on this public profile. See the full cap table on Dealroom →

Talent

Book a demo to see the people

Employees mapped 430 incl. 87 AI specialists

Founders /100 quality score

Key operators 64 quality /100

Potential founders likely future founders

Startup mafia 10 alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

5 of 10 startups shown

Former Owkin employees who went on to found companies, sorted by Dealroom signal score.

Pierre CourtiolFrance

Signal score90

CURE51Est. 2022

Simon IstolainenFrance

Signal score89

EntalpicEst. 2024

Mathieu GaltierFrance

Signal score87

5 more alumni-founded companies in this previewBook a demo

Global footprint

Workforce and web traffic by country

Workforce by country

15 countries with
team presence

🇫🇷 France77.1%

🇬🇧 United Kingdom10.1%

🇺🇸 United States6.3%

🇩🇪 Germany2%

🇧🇪 Belgium0.7%

Top 5 of 15 shown

Web traffic by country

77K monthly visits
across markets

🇮🇳 India22.7%

🇫🇷 France12.3%

🇺🇸 United States10%

🇩🇪 Germany9%

🇬🇧 United Kingdom7.7%

Top 5 markets shown

Patents

Estimated portfolio value

$3M

9 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Owkin was the backer or acquirer, 2023–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Owkin's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount

By stageCount

By periodCount

Owkin's portfolio, mapped.

Stage

Period

3 of 3 deals

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Owkin on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Owkin on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles